Somi Igbene, PhD,  science writer—

AlphaID At Home, a screening kit to detect alpha-1-antitrypsin deficiency (alpha-1), has been cleared by the U.S. Food and Drug Administration (FDA). The free, direct-to-consumer screening kit developed by Grifols will enable adults in the U.S. to determine their genetic risk of developing lung or liver disease linked to…

The University of Massachusetts Chan Medical School and Wellinks have launched “Healthy at Home,” a program to investigate whether virtual care can prevent recurrent illness and reduce health-related costs for people with chronic obstructive pulmonary disease (COPD). The six-month program will test the feasibility of virtual preventive care…